Medac Pharma


 

Enhancing treatment options for patients

Introducing a world of possibilities in proven therapies

With a focus on advancing and commercializing therapies for autoimmune diseases and cancer, we strive to use evidence-based medicine to increase the longevity and quality of people’s lives. We are currently developing a novel methotrexate drug delivery system that has the potential to improve tolerability, increase bioavailability, and enable patients to manage their own therapy.

 

 


About Our Company

Medac Pharma, Inc. is a privately held specialty pharmaceutical company based in Chicago, Illinois.
 
Backed by medac GmbH, a global pharmaceutical company that has been operating in 70 countries for over 40 years, we are independently and aggressively building our operations in the United States, focusing initially on the development and commercialization of treatments for autoimmune diseases and cancer.
 
By forming new partnerships and leveraging our parent company’s strong product pipeline, we have the opportunity to make significant medical advancements that can help patients live better lives.

 

Patients are Our Priority

Medac Pharma, Inc. is focused on improving health outcomes and quality of life for people living with autoimmune diseases and cancer. We work hard to ensure that therapies designed to help our patients live healthy and productive lives are developed and approved as expeditiously as possible.

 


Core Values

We bring unique experiences and expertise to the table, but we all share a set of values that define our company culture.
 

Finding success through collaboration

  • We value teamwork and diversity of thought. New ideas and perspectives can create unique and exciting scientific breakthroughs. We find solutions to problems by working together and drawing on the power and synergy of our combined expertise.

Committing to scientific excellence

  • We hold ourselves to the highest standards of scientific excellence, integrity, and ethics. We strive to identify critical needs in the drug development landscape and challenge ourselves to meet those needs through continuous scientific innovation.

Guided by compassion and respect

  • We care deeply about patients and their healthcare providers. This is why we work tirelessly to ensure that effective treatments are available to those who need them.

 


Chronic Autoimmune Diseases

Autoimmune diseases arise from an inappropriate immune response of the body against substances and tissues normally present in the body.
 
Autoimmune diseases are a family of more than 80 chronic, and often disabling, diseases including rheumatoid arthritis, psoriasis, Crohn’s disease, ulcerative colitis, vasculitis and multiple sclerosis.1,2
 
Patients with autoimmune diseases face a lifetime of illness and treatment. They often endure debilitating symptoms, loss of organ function, reduced productivity at work, and high medical expenses.
 
And, because most of these diseases disproportionately afflict women, and are among the leading causes of death for young and middle-aged women, they impose a heavy burden on patients’ families and on society.1
 
The autoimmune team at Medac Pharma, Inc. is concentrating mainly on rheumatology diseases because early and aggressive therapy can often help slow disease progression.2,3

 

 

References:

1. The Autoimmune Diseases Coordinating Committee. NIH Publication 05-5140. Bethesda, MD: The Autoimmune Diseases Coordinating Committee, National Institute of Allergy and Infectious Diseases, National Institutes of Health; 2005. [accessed 16 May 2013]. Progress in Autoimmune Disease Research. Report to Congress. Available: http://tinyurl.com/3wev5xh.

2. AARDA. List of Autoimmune and Autoimmune-Related Diseases. [accessed 19 May 2013]. Available: https://www.aarda.org/research_display.php?ID=47.

3. Clements JN. Treatment of rheumatoid arthritis: a review of recommendations and emerging therapy. Form. 2011;46:31:532-545.